1 April 2025 false No description of principal activity Taxfiler 2024.6 13983396 business:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 13983396 2025-03-31 13983396 2025-04-01 2026-03-31 13983396 business:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 13983396 business:FilletedAccounts 2025-04-01 2026-03-31 13983396 2026-03-31 13983396 business:Director1 2025-04-01 2026-03-31 13983396 business:Director2 2025-04-01 2026-03-31 13983396 business:RegisteredOffice 2025-04-01 2026-03-31 13983396 2025-03-31 13983396 core:WithinOneYear 2026-03-31 13983396 core:WithinOneYear 2025-03-31 13983396 core:ShareCapital core:PreviouslyStatedAmount 2026-03-31 13983396 core:ShareCapital core:PreviouslyStatedAmount 2025-03-31 13983396 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2026-03-31 13983396 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-03-31 13983396 core:PreviouslyStatedAmount 2026-03-31 13983396 core:PreviouslyStatedAmount 2025-03-31 13983396 business:SmallEntities 2025-04-01 2026-03-31 13983396 countries:EnglandWales 2025-04-01 2026-03-31 13983396 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure
Company Registration No. 13983396 (England and Wales)
Pharma Marketing Solutions ltd Filleted accounts for the year ended 31 March 2026
Pharma Marketing Solutions ltd Filleted accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Pharma Marketing Solutions ltd Company Information for the year ended 31 March 2026
Directors
Giedre Arlauske Mantas Jakimavicius
Company Number
13983396 (England and Wales)
Registered Office
166 COLLEGE ROAD HARROW MIDDLESEX HA1 1BH UNITED KINGDOM
- 3 -
Pharma Marketing Solutions ltd Statement of financial position as at 31 March 2026
2026
2025
Notes
£
£
Current assets
Inventories
9,314
9,589
Debtors
4
3,775
2,126
Cash at bank and in hand
546
11,546
13,635
23,261
Creditors: amounts falling due within one year
5
(48,085)
(20,811)
Net current (liabilities)/assets
(34,450)
2,450
Net (liabilities)/assets
(34,450)
2,450
Capital and reserves
Called up share capital
1
1
Profit and loss account
(34,451)
2,449
Shareholders' funds
(34,450)
2,450
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 3 August 2026 and were signed on its behalf by
Giedre Arlauske Director Company Registration No. 13983396
- 4 -
Pharma Marketing Solutions ltd Notes to the Accounts for the year ended 31 March 2026
1
Statutory information
Pharma Marketing Solutions ltd is a private company, limited by shares, registered in England and Wales, registration number 13983396. The registered office is 166 COLLEGE ROAD, HARROW, MIDDLESEX, HA1 1BH, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
4
Debtors
2026
2025
£
£
Amounts falling due within one year
Trade debtors
3,773
2,126
Other debtors
2
-
3,775
2,126
5
Creditors: amounts falling due within one year
2026
2025
£
£
VAT
3,493
2,935
Trade creditors
44,554
12,007
Taxes and social security
37
4,843
Other creditors
-
1,025
Loans from directors
1
1
48,085
20,811
6
Average number of employees
During the year the average number of employees was 1 (2025: 1).
- 5 -